PortalPublikationenTherapeutic use of medical Cannabis in neurological diseases...

Therapeutic use of medical Cannabis in neurological diseases: a clinical update

Standard

Therapeutic use of medical Cannabis in neurological diseases: a clinical update. / Hidding, Ute; Mainka, Tina; Buhmann, Carsten.

in: J NEURAL TRANSM, Jahrgang 131, Nr. 2, 02.2024, S. 117-126.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Hidding, U, Mainka, T & Buhmann, C 2024, 'Therapeutic use of medical Cannabis in neurological diseases: a clinical update', J NEURAL TRANSM, Jg. 131, Nr. 2, S. 117-126. https://doi.org/10.1007/s00702-023-02719-1

APA

Hidding, U., Mainka, T., & Buhmann, C. (2024). Therapeutic use of medical Cannabis in neurological diseases: a clinical update. J NEURAL TRANSM, 131(2), 117-126. https://doi.org/10.1007/s00702-023-02719-1

Vancouver

Hidding U, Mainka T, Buhmann C. Therapeutic use of medical Cannabis in neurological diseases: a clinical update. J NEURAL TRANSM. 2024 Feb;131(2):117-126. https://doi.org/10.1007/s00702-023-02719-1

Bibtex

@article{0f995439d55349f496c72c2041964f7b,
title = "Therapeutic use of medical Cannabis in neurological diseases: a clinical update",
abstract = "The use of medical Cannabis has increased in recent years due to changing legal circumstances in many countries. Approval exists only for a few neurological conditions such as rare forms of epilepsy or spasticity in multiple sclerosis. Beyond that, however, medical Cannabis is used for a wide range of neurological conditions and symptoms. In Germany, in parallel with new legislation that has simplified the prescription of medical Cannabis, an accompanying survey has been implemented for which initial data are now available. In this context, our review provides an overview of the evidence for the therapeutic use of medical Cannabis in neurology, the potential benefits, and side effects.",
author = "Ute Hidding and Tina Mainka and Carsten Buhmann",
note = "{\textcopyright} 2023. The Author(s).",
year = "2024",
month = feb,
doi = "10.1007/s00702-023-02719-1",
language = "English",
volume = "131",
pages = "117--126",
journal = "J NEURAL TRANSM",
issn = "0300-9564",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Therapeutic use of medical Cannabis in neurological diseases: a clinical update

AU - Hidding, Ute

AU - Mainka, Tina

AU - Buhmann, Carsten

N1 - © 2023. The Author(s).

PY - 2024/2

Y1 - 2024/2

N2 - The use of medical Cannabis has increased in recent years due to changing legal circumstances in many countries. Approval exists only for a few neurological conditions such as rare forms of epilepsy or spasticity in multiple sclerosis. Beyond that, however, medical Cannabis is used for a wide range of neurological conditions and symptoms. In Germany, in parallel with new legislation that has simplified the prescription of medical Cannabis, an accompanying survey has been implemented for which initial data are now available. In this context, our review provides an overview of the evidence for the therapeutic use of medical Cannabis in neurology, the potential benefits, and side effects.

AB - The use of medical Cannabis has increased in recent years due to changing legal circumstances in many countries. Approval exists only for a few neurological conditions such as rare forms of epilepsy or spasticity in multiple sclerosis. Beyond that, however, medical Cannabis is used for a wide range of neurological conditions and symptoms. In Germany, in parallel with new legislation that has simplified the prescription of medical Cannabis, an accompanying survey has been implemented for which initial data are now available. In this context, our review provides an overview of the evidence for the therapeutic use of medical Cannabis in neurology, the potential benefits, and side effects.

U2 - 10.1007/s00702-023-02719-1

DO - 10.1007/s00702-023-02719-1

M3 - SCORING: Review article

C2 - 38015317

VL - 131

SP - 117

EP - 126

JO - J NEURAL TRANSM

JF - J NEURAL TRANSM

SN - 0300-9564

IS - 2

ER -